SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-008070
Filing Date
2024-05-14
Accepted
2024-05-14 08:40:23
Documents
51
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20240514x8k.htm   iXBRL 8-K 41216
2 EX-99.1 apre-20240514xex99d1.htm EX-99.1 109168
3 EX-99.2 apre-20240514xex99d2.htm EX-99.2 56347
4 GRAPHIC apre-20240514xex99d2g001.jpg GRAPHIC 104387
5 GRAPHIC apre-20240514xex99d2g002.jpg GRAPHIC 335207
6 GRAPHIC apre-20240514xex99d2g003.jpg GRAPHIC 177174
7 GRAPHIC apre-20240514xex99d2g004.jpg GRAPHIC 118974
8 GRAPHIC apre-20240514xex99d2g005.jpg GRAPHIC 140835
9 GRAPHIC apre-20240514xex99d2g006.jpg GRAPHIC 187041
10 GRAPHIC apre-20240514xex99d2g007.jpg GRAPHIC 60330
11 GRAPHIC apre-20240514xex99d2g008.jpg GRAPHIC 144469
12 GRAPHIC apre-20240514xex99d2g009.jpg GRAPHIC 186759
13 GRAPHIC apre-20240514xex99d2g010.jpg GRAPHIC 138112
14 GRAPHIC apre-20240514xex99d2g011.jpg GRAPHIC 180652
15 GRAPHIC apre-20240514xex99d2g012.jpg GRAPHIC 62974
16 GRAPHIC apre-20240514xex99d2g013.jpg GRAPHIC 172098
17 GRAPHIC apre-20240514xex99d2g014.jpg GRAPHIC 113708
18 GRAPHIC apre-20240514xex99d2g015.jpg GRAPHIC 168880
19 GRAPHIC apre-20240514xex99d2g016.jpg GRAPHIC 148724
20 GRAPHIC apre-20240514xex99d2g017.jpg GRAPHIC 121266
21 GRAPHIC apre-20240514xex99d2g018.jpg GRAPHIC 137232
22 GRAPHIC apre-20240514xex99d2g019.jpg GRAPHIC 61156
23 GRAPHIC apre-20240514xex99d2g020.jpg GRAPHIC 232620
24 GRAPHIC apre-20240514xex99d2g021.jpg GRAPHIC 167861
25 GRAPHIC apre-20240514xex99d2g022.jpg GRAPHIC 163322
26 GRAPHIC apre-20240514xex99d2g023.jpg GRAPHIC 165872
27 GRAPHIC apre-20240514xex99d2g024.jpg GRAPHIC 138924
28 GRAPHIC apre-20240514xex99d2g025.jpg GRAPHIC 131769
29 GRAPHIC apre-20240514xex99d2g026.jpg GRAPHIC 98543
30 GRAPHIC apre-20240514xex99d2g027.jpg GRAPHIC 125062
31 GRAPHIC apre-20240514xex99d2g028.jpg GRAPHIC 65543
32 GRAPHIC apre-20240514xex99d2g029.jpg GRAPHIC 163315
33 GRAPHIC apre-20240514xex99d2g030.jpg GRAPHIC 101682
34 GRAPHIC apre-20240514xex99d2g031.jpg GRAPHIC 133301
35 GRAPHIC apre-20240514xex99d2g032.jpg GRAPHIC 88159
36 GRAPHIC apre-20240514xex99d2g033.jpg GRAPHIC 163082
37 GRAPHIC apre-20240514xex99d2g034.jpg GRAPHIC 150864
38 GRAPHIC apre-20240514xex99d2g035.jpg GRAPHIC 158199
  Complete submission text file 0001558370-24-008070.txt   7267428

Data Files

Seq Description Document Type Size
39 EX-101.SCH apre-20240514.xsd EX-101.SCH 3995
40 EX-101.DEF apre-20240514_def.xml EX-101.DEF 2844
41 EX-101.LAB apre-20240514_lab.xml EX-101.LAB 17245
42 EX-101.PRE apre-20240514_pre.xml EX-101.PRE 11355
54 EXTRACTED XBRL INSTANCE DOCUMENT apre-20240514x8k_htm.xml XML 4859
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 24941587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)